29
Mar
2020
As COVID19 Comes to India, Expect Drug Supplies to Run Short
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
29
Mar
2020
COVID-19 Teaches Us the Real Definition of a ‘Novel’ Drug
Will the world care how we beat COVID-19 – whether with a drug we make from scratch or an older one that turns out to get the job done? As people concerned for our families, we all know the answer. Just get it done! But as drug developers, let’s be honest that it doesn’t feel quite as heroic unless it’s... Read More